Back
bluebird bio 10K Form
Sell
22
BLUE
bluebird bio
Last Price:
0.36
Seasonality Move:
6.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BLUE News And Ratings
See the #1 stock for the next 7 days that we like better than BLUE
BLUE Financial Statistics
Sales & Book Value
| Annual Sales: | $29.5M |
|---|---|
| Cash Flow: | $-66.31M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.27 |
| Price / Book: | 1.43 |
Profitability
| EPS (TTM): | -2.22000 |
|---|---|
| Net Income (TTM): | $-311.44M |
| Gross Margin: | $-4.03M |
| Return on Equity: | -174.94% |
| Return on Assets: | -50.68% |
bluebird bio Earnings Forecast
Key bluebird bio Financial Ratios
- The Gross Profit Margin over the past 17 years for BLUE is -13.66%.
- The Selling, General & Administrative Expenses for BLUE have been equal to 561.11% of Gross Profit Margin.
- The Research & Development expenses have been 568.37% of Revenue.
- The Interest Expense is -7.72% of Operating Income.
- The Net Earning history of BLUE is -718.42% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 10 years.
bluebird bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BLUE |
| CUSIP: | 09609G |
| Website: | bluebirdbio.com |
Debt
| Debt-to-Equity Ratio: | 1.32 |
|---|---|
| Current Ratio: | 0.68 |
| Quick Ratio: | 0.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BLUE Technical Analysis vs Fundamental Analysis
Sell
22
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy or a Sell?
-
bluebird bio stock is rated a Sell
The current bluebird bio [BLUE] share price is $0.38. The Score for BLUE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.